TM4SF1 as a Prognostic Biomarker and Therapeutic Target in Cervical Cancer

2025/11/03 by Juexiao Deng, Jue-xiao Deng, Lanyue Zhang +8 · 1 voice
Immunology and Microbiology · Medicine · #Endometrial and Cervical Cancer Treatments #Preterm Birth and Chorioamnionitis #Reproductive System and Pregnancy

paper · doi:10.1007/s11596-025-00123-2

crossref issued 2025/11/03 · crossref published 2025/11/03 · crossref published-online 2025/11/03 · openalex created_date 2025/11/03 · openalex publication_date 2025/11/03 · crossref created 2025/11/03 · crossref published-print 2025/12/01 · crossref deposited 2025/12/29 · crossref indexed 2025/12/29 · openalex updated_date 2026/07/23

Citations

• Immune Checkpoint Inhibitors: Basics and Challenges
• TIMER2.0 for analysis of tumor-infiltrating immune cells
• Cancer statistics for the year 2020: An overview
• clusterProfiler 4.0: A universal enrichment tool for interpreting omics data
• UALCAN: An update to the integrated cancer data analysis platform

Discussions

• This study investigates the associations between #TM4SF1 expression and #clinicopathological features in #CervicalCancer, contributing to a deeper understanding of its biological roles and potential i [bsky, 1 points, 0 comments]